Stocks in Focus: Aurobindo Pharma, GAIL (India), and Others

The GIFT Nifty futures, which are an early indicator of the Nifty50 index stocks, were trading higher by 679 points at 23,830, indicating that the domestic benchmark indices are likely to make a blockbuster start on Wednesday. 

Earlier on Tuesday, 7 April, the domestic benchmark indices S&P BSE Sensex surged by 509 points or 0.69%, and settled at 74,616, while the Nifty50 traded 0.68% higher or 155 points, closing at 23,123.

Here are some stocks that are likely to remain in focus on 8 April.

Aurobindo Pharma: The company secured final approval from the US Food and Drug Administration to manufacture and market Dapagliflozin and Metformin hydrochloride extended-release tablets in multiple strengths. These drugs are bioequivalent to AstraZeneca’s Xigduo XR.

GAIL (India): The company entered into a long-term charter party agreement with Alpha Gas for the LNG carrier Energy Fidelity. GAIL executed the agreement with Pantheon Maritime Services, a Singapore-based affiliate of Alpha Gas.

Prostarm Indo Systems: The company received a Letter of Award from Solarium Green Energy to execute EPC work worth Rs 165 crore for a 50 MWac solar PV project in Maharashtra. It also signed an MoU with Shenzhen Topband Co to explore a strategic partnership in battery energy storage systems (BESS).

Swan Defence: The company secured a Rs 1,500–3,000 crore order from Energy ONE to build four 92,500 DWT dual-fuel ammonia bulk carriers, the first such vessels to be built in India. It expects to deliver the first ship by October 2029.

Biocon: The company launched Bosaya and Aukelso (denosumab-kyqq) in the United States after receiving approval and interchangeable designation from the USFDA in September 2025.

Arvind SmartSpaces: The company signed a residential high-rise project in Goregaon (West), Mumbai, with a topline potential of around Rs 2,400 crore and a saleable carpet area of about 0.67 million sq ft, in partnership with Sigma Oxford Realtors.

Dredging Corporation of India: The company signed a significant Memorandum of Understanding (MoU) with Colombo Dockyard Plc, strengthening maritime cooperation between India and Sri Lanka.

Clean Max Enviro: The company commissioned its 185 MW hybrid renewable energy project at Kalavad, developed over 12 months. The project will supply green energy to 17 corporate clients and is expected to contribute over Rs 165 crore annually to revenue from FY27 once stabilised.

The future of investing is here!
Tradz by EquityPandit leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

The post Stocks in Focus: Aurobindo Pharma, GAIL (India), and Others appeared first on Equitypandit.